How did IOVA's Q4 2024 EPS surprise analysts?
4/11/2025 04:29pm
Iovance Therapeutics (IOVA) reported an EPS surprise of $0.01 for Q4 2024, which suggests that the company's actual performance exceeded analysts' expectations by a small margin. This positive surprise could be indicative of the company's strong financial performance and potential growth prospects.